GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BIO-FD&C Co Ltd (XKRX:251120) » Definitions » Capex-to-Operating-Income

BIO-FD&C Co (XKRX:251120) Capex-to-Operating-Income : 0.91 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is BIO-FD&C Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

BIO-FD&C Co's Capital Expenditure for the three months ended in Mar. 2024 was ₩-882.57 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩965.49 Mil.

Hence, BIO-FD&C Co's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 0.91.


BIO-FD&C Co Capex-to-Operating-Income Historical Data

The historical data trend for BIO-FD&C Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-FD&C Co Capex-to-Operating-Income Chart

BIO-FD&C Co Annual Data
Trend Dec15 Dec16 Dec18 Dec19 Dec20 Dec21 Dec22
Capex-to-Operating-Income
Get a 7-Day Free Trial 4.75 0.10 0.65 2.24 0.05

BIO-FD&C Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.33 1.03 0.12 0.91

Competitive Comparison of BIO-FD&C Co's Capex-to-Operating-Income

For the Biotechnology subindustry, BIO-FD&C Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIO-FD&C Co's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BIO-FD&C Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where BIO-FD&C Co's Capex-to-Operating-Income falls into.



BIO-FD&C Co Capex-to-Operating-Income Calculation

BIO-FD&C Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-224.947) / 4880.636
=0.05

BIO-FD&C Co's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-882.569) / 965.491
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIO-FD&C Co  (XKRX:251120) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


BIO-FD&C Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of BIO-FD&C Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


BIO-FD&C Co (XKRX:251120) Business Description

Traded in Other Exchanges
N/A
Address
30, Songdomirae-ro, Yeonsu-gu, 509-512, B07, A-dong, Smartvalley, Incheon, KOR
BIO-FD&C Co Ltd is engaged in dealing with anti-aging and health materials using sustainable bio-cultivation technology. Its products include Plant cell, Peptide, Herbal Extract and Biomolecule.

BIO-FD&C Co (XKRX:251120) Headlines

No Headlines